Mass spectrometry (MS) is a powerful analytical technique that has become increasingly important in clinical research. It is a highly sensitive and specific method for identifying and quantifying molecules in complex biological samples, such as blood, urine and tissue. Using mass spectrometry, it is possible to detect and measure small molecules, proteins, peptides and metabolites in biological samples. This enables researchers to better understand the underlying mechanisms of diseases, identify biomarkers for early disease detection and develop more targeted and personalized treatments.
SCIEX has a long history of providing cutting-edge tools for clinical research. See how SCIEX technologies are utilized daily in identifying and quantifying new and emerging biomarkers and metabolites, whether they are small molecules, proteins or lipids. Learn how to empower your research while developing novel testing protocols for improving human health. SCIEX is the ideal partner for addressing these concerns and helping your clinical research laboratory meet its analytical goals now and in the future. We provide a strong portfolio of mass spectrometers, workflow solutions, software, aftercare and third-party relationships to meet and exceed your daily needs. In addition, as next-generation research into disease and medicine dictates the needs of tomorrow, you can be ready to respond with robust, sensitive and easy-to-use systems from SCIEX—such as the QTRAP 6500+ system— to support the entire clinical research laboratory pipeline. Scientists trust us to advance their work in clinical research.
